Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Dec;48(6):M302–M306. doi: 10.1136/mp.48.6.m302

The role of human leucocyte antigen genes in the development of malignant disease

W M Howell 1,2, D B Jones 1,2
PMCID: PMC407994  PMID: 16696027

Full text

PDF
M302

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfsen G. C., Beiske K., Bell H., Marton P. F. Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. Hum Pathol. 1989 Sep;20(9):909–913. doi: 10.1016/0046-8177(89)90105-6. [DOI] [PubMed] [Google Scholar]
  2. Apple R. J., Erlich H. A., Klitz W., Manos M. M., Becker T. M., Wheeler C. M. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet. 1994 Feb;6(2):157–162. doi: 10.1038/ng0294-157. [DOI] [PubMed] [Google Scholar]
  3. Barger B. O., Acton R. T., Soong S. J., Roseman J., Balch C. Increase of HLA-DR4 in melanoma patients from Alabama. Cancer Res. 1982 Oct;42(10):4276–4279. [PubMed] [Google Scholar]
  4. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T. Nomenclature for factors of the HLA system, 1994. Tissue Antigens. 1994 Jul;44(1):1–18. doi: 10.1111/j.1399-0039.1994.tb02351.x. [DOI] [PubMed] [Google Scholar]
  5. Bodmer J. G., Tonks S., Oza A. M., Lister T. A., Bodmer W. F. HLA-DP based resistance to Hodgkin's disease. Lancet. 1989 Jun 24;1(8652):1455–1456. doi: 10.1016/s0140-6736(89)90166-9. [DOI] [PubMed] [Google Scholar]
  6. Branch P., Bicknell D. C., Rowan A., Bodmer W. F., Karran P. Immune surveillance in colorectal carcinoma. Nat Genet. 1995 Mar;9(3):231–232. doi: 10.1038/ng0395-231. [DOI] [PubMed] [Google Scholar]
  7. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993 Jul 1;364(6432):33–39. doi: 10.1038/364033a0. [DOI] [PubMed] [Google Scholar]
  8. Cerimele D., Contu L., Carcassi C., Costa G., La Nasa G., Sanna E., Campus G. V. HLA and multiple skin carcinomas. Dermatologica. 1988;176(4):176–181. doi: 10.1159/000248700. [DOI] [PubMed] [Google Scholar]
  9. Congia M., Cucca F., Frau F., Lampis R., Melis L., Clemente M. G., Cao A., De Virgiliis S. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol. 1994 Jun;40(2):138–142. doi: 10.1016/0198-8859(94)90059-0. [DOI] [PubMed] [Google Scholar]
  10. Cuzick J., Terry G., Ho L., Hollingworth T., Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer. 1994 Jan;69(1):167–171. doi: 10.1038/bjc.1994.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Czarnecki D., Lewis A., Nicholson I., Tait B. Multiple basal cell carcinomas and HLA frequencies in southern Australia. J Am Acad Dermatol. 1991 Apr;24(4):559–561. doi: 10.1016/0190-9622(91)70082-d. [DOI] [PubMed] [Google Scholar]
  12. Czarnecki D., Lewis A., Nicholson I., Tait B., Nash C. HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas. J Am Acad Dermatol. 1992 May;26(5 Pt 1):717–719. doi: 10.1016/0190-9622(92)70099-2. [DOI] [PubMed] [Google Scholar]
  13. Czarnecki D., Watkins F., Leahy S., Dyall-Smith D., Levis A., Nicholson I., Tait B. Skin cancers and HLA frequencies in renal transplant recipients. Dermatology. 1992;185(1):9–11. doi: 10.1159/000247394. [DOI] [PubMed] [Google Scholar]
  14. Czarnecki D., Zalcberg J., Nicholson I., Tait B. Skin cancer and HLA antigens. N Engl J Med. 1992 Mar 12;326(11):765–766. [PubMed] [Google Scholar]
  15. David A. L., Taylor G. M., Gokhale D., Aplin J. D., Seif M. W., Tindall V. R. HLA-DQB1*03 and cervical intraepithelial neoplasia type III. Lancet. 1992 Jul 4;340(8810):52–52. doi: 10.1016/0140-6736(92)92464-q. [DOI] [PubMed] [Google Scholar]
  16. Ellis J. R., Keating P. J., Baird J., Hounsell E. F., Renouf D. V., Rowe M., Hopkins D., Duggan-Keen M. F., Bartholomew J. S., Young L. S. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995 May;1(5):464–470. doi: 10.1038/nm0595-464. [DOI] [PubMed] [Google Scholar]
  17. Fossum B., Breivik J., Meling G. I., Gedde-Dahl T., 3rd, Hansen T., Knutsen I., Rognum T. O., Thorsby E., Gaudernack G. A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation? Int J Cancer. 1994 Aug 15;58(4):506–511. doi: 10.1002/ijc.2910580409. [DOI] [PubMed] [Google Scholar]
  18. Glew S. S., Duggan-Keen M., Ghosh A. K., Ivinson A., Sinnott P., Davidson J., Dyer P. A., Stern P. L. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol. 1993 Jul;37(3):157–164. doi: 10.1016/0198-8859(93)90181-y. [DOI] [PubMed] [Google Scholar]
  19. Gregoire L., Lawrence W. D., Kukuruga D., Eisenbrey A. B., Lancaster W. D. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer. 1994 May 15;57(4):504–507. doi: 10.1002/ijc.2910570411. [DOI] [PubMed] [Google Scholar]
  20. Howell W. M. HLA immunogenetics and specific IgE responses to allergens. Clin Exp Allergy. 1994 May;24(5):401–404. doi: 10.1111/j.1365-2222.1994.tb00926.x. [DOI] [PubMed] [Google Scholar]
  21. Howell W. M., Leung S. T., Jones D. B., Nakshabendi I., Hall M. A., Lanchbury J. S., Ciclitira P. J., Wright D. H. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol. 1995 May;43(1):29–37. doi: 10.1016/0198-8859(94)00130-i. [DOI] [PubMed] [Google Scholar]
  22. Isaacson P. G., O'Connor N. T., Spencer J., Bevan D. H., Connolly C. E., Kirkham N., Pollock D. J., Wainscoat J. S., Stein H., Mason D. Y. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet. 1985 Sep 28;2(8457):688–691. doi: 10.1016/s0140-6736(85)92930-7. [DOI] [PubMed] [Google Scholar]
  23. Jones E. H., Biggar R. J., Nkrumah F. K., Lawler S. D. Study of the HLA system in Burkitt's lymphoma. Hum Immunol. 1980 Oct;1(3):207–210. doi: 10.1016/0198-8859(80)90015-4. [DOI] [PubMed] [Google Scholar]
  24. Lee J. E., Reveille J. D., Ross M. I., Platsoucas C. D. HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer. 1994 Nov 15;59(4):510–513. doi: 10.1002/ijc.2910590413. [DOI] [PubMed] [Google Scholar]
  25. Lundin K. E., Gjertsen H. A., Scott H., Sollid L. M., Thorsby E. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994 Sep;41(1):24–27. doi: 10.1016/0198-8859(94)90079-5. [DOI] [PubMed] [Google Scholar]
  26. Mignot E., Lin X., Arrigoni J., Macaubas C., Olive F., Hallmayer J., Underhill P., Guilleminault C., Dement W. C., Grumet F. C. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep. 1994 Dec;17(8 Suppl):S60–S67. doi: 10.1093/sleep/17.suppl_8.s60. [DOI] [PubMed] [Google Scholar]
  27. Mueller-Eckhardt G., Schendel D. J., Hundeiker M., Riedel T., O'Neill G. J., Riethmüller G., Mueller-Eckhardt C. Possible association between HLA-DR5 and superficial spreading melanoma (SSM). Int J Cancer. 1984 Dec 15;34(6):751–755. doi: 10.1002/ijc.2910340603. [DOI] [PubMed] [Google Scholar]
  28. Muñoz N., Bosch F. X., de Sanjosé S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992 Nov 11;52(5):743–749. doi: 10.1002/ijc.2910520513. [DOI] [PubMed] [Google Scholar]
  29. Nuovo G. J., Blanco J. S., Leipzig S., Smith D. Human papillomavirus detection in cervical lesions nondiagnostic for cervical intraepithelial neoplasia: correlation with Papanicolaou smear, colposcopy, and occurrence of cervical intraepithelial neoplasia. Obstet Gynecol. 1990 Jun;75(6):1006–1011. [PubMed] [Google Scholar]
  30. Oksenberg J. R., Begovich A. B., Erlich H. A., Steinman L. Genetic factors in multiple sclerosis. JAMA. 1993 Nov 17;270(19):2362–2369. [PubMed] [Google Scholar]
  31. Pawelec G., Ehninger G., Müller C., Blaurock M., Schneider E. M., Wernet P. Human leukocyte antigen-DP in leukemia. Cancer. 1988 Feb 1;61(3):475–477. doi: 10.1002/1097-0142(19880201)61:3<475::aid-cncr2820610311>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  32. Ploski R., Ek J., Thorsby E., Sollid L. M. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens. 1993 Apr;41(4):173–177. doi: 10.1111/j.1399-0039.1993.tb01998.x. [DOI] [PubMed] [Google Scholar]
  33. Poppema S., Visser L. Absence of HLA class I expression by Reed-Sternberg cells. Am J Pathol. 1994 Jul;145(1):37–41. [PMC free article] [PubMed] [Google Scholar]
  34. Scorza Smeraldi R., Fabio G., Lazzarin A., Eisera N. B., Moroni M., Zanussi C. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet. 1986 Nov 22;2(8517):1187–1189. doi: 10.1016/s0140-6736(86)92197-5. [DOI] [PubMed] [Google Scholar]
  35. Taylor G. M., Robinson M. D., Binchy A., Birch J. M., Stevens R. F., Jones P. M., Carr T., Dearden S., Gokhale D. A. Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukaemia supports an infectious aetiology. Leukemia. 1995 Mar;9(3):440–443. [PubMed] [Google Scholar]
  36. Thorsby E., Rønningen K. S. Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann Med. 1992 Dec;24(6):523–531. doi: 10.3109/07853899209167006. [DOI] [PubMed] [Google Scholar]
  37. Vandenvelde C., De Foor M., van Beers D. HLA-DOB1*03 and cervical intraepithelial neoplasia grades I-III. Lancet. 1993 Feb 13;341(8842):442–442. doi: 10.1016/0140-6736(93)93044-2. [DOI] [PubMed] [Google Scholar]
  38. Wank R., Meulen J. T., Luande J., Eberhardt H. C., Pawlita M. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles. Lancet. 1993 May 8;341(8854):1215–1215. doi: 10.1016/0140-6736(93)91043-l. [DOI] [PubMed] [Google Scholar]
  39. Wank R., Schendel D. J., Thomssen C. HLA antigens and cervical carcinoma. Nature. 1992 Mar 5;356(6364):22–23. doi: 10.1038/356022b0. [DOI] [PubMed] [Google Scholar]
  40. Wank R., Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature. 1991 Aug 22;352(6337):723–725. doi: 10.1038/352723a0. [DOI] [PubMed] [Google Scholar]
  41. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol. 1994;56:389–466. doi: 10.1016/s0065-2776(08)60456-3. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES